|
JP5435592B2
(ja)
|
2008-05-28 |
2014-03-05 |
ファイザー・インク |
ピラゾロスピロケトンアセチルＣｏＡカルボキシラーゼ阻害剤
|
|
ES2444543T3
(es)
|
2009-11-10 |
2014-02-25 |
Pfizer Inc |
Inhibidores de la N1-pirazoloespirocetona acetil-CoA carboxilasa
|
|
KR101455917B1
(ko)
|
2010-03-19 |
2014-11-03 |
화이자 인코포레이티드 |
2,3-디히드로-1h-인덴-1-일-2,7-디아자스피로[3.5]노난 유도체 및 그렐린 수용체의 길항제 또는 역 작용제로서의 그 용도
|
|
US9006450B2
(en)
*
|
2010-07-01 |
2015-04-14 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
EP2621493B1
(en)
|
2010-09-30 |
2016-08-17 |
Pfizer Inc |
N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
|
|
CN104774205A
(zh)
|
2010-10-29 |
2015-07-15 |
辉瑞大药厂 |
N1/n2-内酰胺乙酰辅酶a羧化酶抑制剂
|
|
JP5657174B2
(ja)
|
2011-04-22 |
2015-01-21 |
ファイザー・インク |
アセチルＣｏＡカルボキシラーゼ阻害剤として使用するためのピラゾロスピロケトン誘導体
|
|
CA2841757A1
(en)
|
2011-07-15 |
2013-01-24 |
Etzer Darout |
Gpr 119 modulators
|
|
BR112014000288A2
(pt)
|
2011-07-22 |
2017-01-10 |
Pfizer |
moduladores do receptor de glucagon de quinolinila
|
|
EP2751116B1
(en)
|
2011-08-31 |
2016-10-12 |
Pfizer Inc |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
BR112014011254A2
(pt)
|
2011-11-11 |
2017-05-16 |
Pfizer |
2-tiopirimidinonas
|
|
SG11201405477XA
(en)
|
2012-04-06 |
2014-11-27 |
Pfizer |
Diacylglycerol acyltransferase 2 inhibitors
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
WO2013164730A1
(en)
|
2012-05-04 |
2013-11-07 |
Pfizer Inc. |
Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin- 2 -amine compounds as inhibitors of app, bace1 and bace 2.
|
|
CA2882389A1
(en)
|
2012-09-20 |
2014-03-27 |
Pfizer Inc. |
Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
WO2014091352A1
(en)
|
2012-12-11 |
2014-06-19 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
EP2935282A1
(en)
|
2012-12-19 |
2015-10-28 |
Pfizer Inc. |
CARBOCYCLIC- AND HETEROCYCLIC-SUBSTITUTED HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS
|
|
JP2016507551A
(ja)
|
2013-02-13 |
2016-03-10 |
ファイザー・インク |
ヘテロアリール置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
BR112016004118A2
(pt)
|
2013-09-12 |
2017-10-17 |
Pfizer |
uso de inibidores da acetil-coa carboxilase para tratamento de acne vulgar
|
|
ES2665153T3
(es)
|
2013-10-09 |
2018-04-24 |
Pfizer Inc. |
Antagonistas del receptor EP3 de prostaglandina
|
|
TR201809388T4
(tr)
|
2014-03-17 |
2018-07-23 |
Pfizer |
Metabolik ve ilişkili hastalıkların tedavisinde kullanılmaya yönelik diasilgliserol asiltransferaz 2 inhibitörleri.
|
|
HUE044180T2
(hu)
|
2014-04-04 |
2019-10-28 |
Pfizer |
Biciklusos kondenzált heteroaril- vagy aril-vegyületek és ezek alkalmazása IRAK4 inhibitorokként
|
|
PE20170327A1
(es)
|
2014-04-10 |
2017-04-21 |
Pfizer |
2-AMINO-6-METIL-4,4a,5,6-TETRAHIDROPIRANO[3,4d] [1,3] TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS
|
|
EP3194367B1
(en)
*
|
2014-09-17 |
2021-08-18 |
Boehringer Ingelheim International GmbH |
Tetrahydroisoquinoline derivatives and pharmaceutical compositions useful for the treatment of obesity and diabetes
|
|
WO2016092413A1
(en)
|
2014-12-10 |
2016-06-16 |
Pfizer Inc. |
Indole and indazole compounds that activate ampk
|
|
JP2017538769A
(ja)
|
2014-12-22 |
2017-12-28 |
ファイザー・インク |
プロスタグランジンｅｐ３受容体の拮抗薬
|
|
BR112017022340A2
(pt)
|
2015-05-05 |
2018-07-10 |
Pfizer |
2-tiopirimidinonas
|
|
JP2018516254A
(ja)
|
2015-05-29 |
2018-06-21 |
ファイザー・インク |
バニン１酵素の阻害薬としての新規なヘテロ環化合物
|
|
UA125334C2
(uk)
|
2015-06-17 |
2022-02-23 |
Пфайзер Інк. |
Трициклічні сполуки та їх застосування як інгібіторів фосфодіестерази
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
JP2018527337A
(ja)
|
2015-08-13 |
2018-09-20 |
ファイザー・インク |
二環式縮合ヘテロアリールまたはアリール化合物
|
|
JP6804524B2
(ja)
|
2015-08-27 |
2020-12-23 |
ファイザー・インク |
Ｉｒａｋ４モジュレーターとしての二環式縮合ヘテロアリールまたはアリール化合物
|
|
WO2017037567A1
(en)
|
2015-09-03 |
2017-03-09 |
Pfizer Inc. |
Regulators of frataxin
|
|
EP3353183A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3]thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl]amides
|
|
EP3353182A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
|
|
EP3353174A1
(en)
|
2015-09-24 |
2018-08-01 |
Pfizer Inc |
N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl]amides useful as bace inhibitors
|
|
CU24540B1
(es)
|
2015-12-29 |
2021-08-06 |
Pfizer |
3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa
|
|
CN109328193A
(zh)
|
2016-04-19 |
2019-02-12 |
尤瑞卡有限公司 |
肽-低聚脲折叠体化合物及其使用方法
|
|
US10906888B2
(en)
|
2016-07-14 |
2021-02-02 |
Pfizer Inc. |
Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
|
|
AR109179A1
(es)
|
2016-08-19 |
2018-11-07 |
Pfizer |
Inhibidores de diacilglicerol aciltransferasa 2
|
|
WO2019133445A1
(en)
|
2017-12-28 |
2019-07-04 |
Inception Ibd, Inc. |
Aminothiazoles as inhibitors of vanin-1
|
|
CN112955147A
(zh)
|
2018-08-31 |
2021-06-11 |
辉瑞公司 |
用于治疗nash/nafld和相关疾病的组合
|
|
WO2020102575A1
(en)
|
2018-11-16 |
2020-05-22 |
Inception Ibd, Inc. |
Heterocyclic aminothiazoles and uses thereof
|
|
US12479816B2
(en)
|
2019-02-08 |
2025-11-25 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
20-HETE formation inhibitors
|
|
WO2020234726A1
(en)
|
2019-05-20 |
2020-11-26 |
Pfizer Inc. |
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
|
|
CN110922372A
(zh)
*
|
2019-11-04 |
2020-03-27 |
天津大学 |
达格列净的氨基酸共晶物及其制备方法
|
|
PH12022552056A1
(en)
|
2020-02-07 |
2024-02-12 |
Gasherbrum Bio Inc |
Heterocyclic glp-1 agonists
|
|
AU2021275292A1
(en)
*
|
2020-05-21 |
2022-12-15 |
Shionogi & Co., Ltd. |
Pharmaceutical for treating fatty liver diseases
|
|
JP2025509281A
(ja)
|
2022-03-09 |
2025-04-11 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環式ｇｌｐ－１アゴニスト
|
|
WO2023198140A1
(en)
|
2022-04-14 |
2023-10-19 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
WO2024118524A1
(en)
|
2022-11-28 |
2024-06-06 |
Cerevel Therapeutics, Llc |
Azaindole compounds and their use as phosphodiesterase inhibitors
|
|
WO2024125602A1
(en)
|
2022-12-15 |
2024-06-20 |
Gasherbrum Bio, Inc. |
Salts and solid forms of a compound having glp-1 agonist activity
|